A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

Sponsor
Proper Wild, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT05857956
Collaborator
Citruslabs (Industry)
40
1
1
1.5
26.5

Study Details

Study Description

Brief Summary

This is a virtual, single-arm clinical trial that will last 28 days. Participants will drink 1 bottle of Proper Wild energy shot daily and complete questionnaires at baseline, day 1, day 14, and day 28.

Attention deficit hyperactivity disorder (ADHD)-like symptoms, such as concentration, focus, and attention, will be evaluated at baseline and at each check-in. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Condition or Disease Intervention/Treatment Phase
  • Other: Proper Wild energy shot
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms
Actual Study Start Date :
Feb 24, 2023
Actual Primary Completion Date :
Apr 7, 2023
Actual Study Completion Date :
Apr 11, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Proper Wild energy shot

Participants will take one bottle daily of Proper Wild Energy shot in the morning. Participants will be advised to drink one bottle in the morning, with or without a meal, depending on their preference, as a replacement for their usual first caffeinated beverage of the day.

Other: Proper Wild energy shot
100% plant-based energy shot containing natural caffeine, L-Theanine, purified water, pineapple juice concentrate, natural flavors, kiwi juice concentrate, organic lemon juice concentrate, organic strawberry juice concentrate, monk fruit juice concentrate, pink himalayan sea salt.

Outcome Measures

Primary Outcome Measures

  1. Change in Attention-deficit/hyperactivity disorder (ADHD)-like symptoms. [Time Frame: Baseline to Day 28] [28 days]

    Survey-based assessment (0-5) scale of changes in symptoms associated with ADHD. Parameters explored include focus & concentration, productivity, mood, and "brain fog".

Secondary Outcome Measures

  1. Assess the product as a replacement for coffee or caffeinated beverages. [Time Frame: Baseline to Day 28] [28 days]

    Survey-based assessment regarding changes in daily coffee/beverage consumption, stress, anxiety, jitters, energy crash, and gastrointestinal upset. Responses will be statistically analyzed and reported as % of subject responses.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Currently experiencing symptoms associated with ADHD, including:

Impulsiveness. Disorganization and problems prioritizing Poor time management skills Problems focusing on a task Trouble multitasking Excessive activity or restlessness Poor planning

  • Age 18-55

  • Self-reported issues with focus and/or productivity

  • Generally healthy - don't live with any uncontrolled chronic disease

Exclusion Criteria:
  • Currently taking prescription medication for ADHD

  • Currently supplementing with L-Theanine.

  • Known to respond negatively to caffeine (no effect, makes them sleepy or feel unwell)

  • People with a high caffeine tolerance defined as regular consumption of >400mg of caffeine (>4 coffees) per day.

  • Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.

  • Anyone with known severe allergic reactions.

  • Women who are pregnant, breastfeeding, or attempting to become pregnant

  • Unwilling to follow the study protocol.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Citruslabs Santa Monica California United States 90404

Sponsors and Collaborators

  • Proper Wild, Inc.
  • Citruslabs

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Proper Wild, Inc.
ClinicalTrials.gov Identifier:
NCT05857956
Other Study ID Numbers:
  • 20290
First Posted:
May 15, 2023
Last Update Posted:
May 15, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 15, 2023